United Services Automobile Association’s Matinas BioPharma MTNB Stock Holding History

United Services Automobile Association’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-224	Closed	-$10K	–	1252
2019 Q2	$10K	Hold	224	–	–	﹤0.01%	2221
2019 Q1	$12K	Hold	224	–	–	﹤0.01%	2244
2018 Q4	$7K	Hold	224	–	–	﹤0.01%	2228
2018 Q3	$10K	Hold	224	–	–	﹤0.01%	2303
2018 Q2	$5K	Hold	224	–	–	﹤0.01%	2296
2018 Q1	$9K	Buy	+224	New	+$11.8K	﹤0.01%	2263

Other funds holding MTNB

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

United Services Automobile Association's MTNB Position: Q3 2019 in Review

United Services Automobile Association sold out of Matinas BioPharma (MTNB) in Q3 2019, closing a stake of 224 shares — an estimated $10K sold.

United Services Automobile Association first reported a position in MTNB in Q1 2018 and held it in 6 quarters. The position peaked at $12K in Q1 2019. 37 funds tracked by Wall St. Rank hold MTNB as of Q3 2019.

United Services Automobile Association reported no remaining Matinas BioPharma position as of Q3 2019 after selling out during the quarter.
United Services Automobile Association sold 224 Matinas BioPharma shares in Q3 2019, an estimated $10K.
United Services Automobile Association first reported a position in Matinas BioPharma in Q1 2018 and held it in 6 quarters.
United Services Automobile Association's Matinas BioPharma position peaked at $12K in Q1 2019.
37 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.